Literature DB >> 20934534

Lyotropic liquid crystal systems in drug delivery.

Chenyu Guo1, Jun Wang, Fengliang Cao, Robert J Lee, Guangxi Zhai.   

Abstract

Lyotropic liquid crystal systems, such as reversed bicontinuous cubic and hexagonal mesophases, are attracting more and more attention because of their unique microstructures and physicochemical properties. Various bioactive molecules such as chemical drugs, peptides and proteins can be solubilized in either aqueous or oil phase and be protected from hydrolysis or oxidation. Furthermore, several studies have demonstrated sustained release of bioactive molecules from reversed cubic and hexagonal mesophases. This article gives an overview of recent advances and current status of reversed cubic and hexagonal mesophases, especially with respect to their preparation methods and applications in the field of drug delivery. In addition, potential problems and possible future research directions are highlighted.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2010        PMID: 20934534     DOI: 10.1016/j.drudis.2010.09.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  28 in total

1.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

Review 2.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

Review 3.  Liquid Crystalline Phases for Enhancement of Oral Bioavailability.

Authors:  Xingwang Zhang; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2021-02-22       Impact factor: 3.246

4.  Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.

Authors:  Thiagarajan Madheswaran; Rengarajan Baskaran; Raj Kumar Thapa; Jeong Yeon Rhyu; Hye Yoon Choi; Jong Oh Kim; Chul Soon Yong; Bong Kyu Yoo
Journal:  AAPS PharmSciTech       Date:  2012-12-04       Impact factor: 3.246

5.  An X-ray transparent microfluidic platform for screening of the phase behavior of lipidic mesophases.

Authors:  Daria S Khvostichenko; Elena Kondrashkina; Sarah L Perry; Ashtamurthy S Pawate; Keith Brister; Paul J A Kenis
Journal:  Analyst       Date:  2013-07-24       Impact factor: 4.616

6.  Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.

Authors:  Sanyog Jain; Neha Bhankur; Nitin K Swarnakar; Kaushik Thanki
Journal:  Pharm Res       Date:  2015-05-13       Impact factor: 4.200

7.  In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Authors:  Larissa Bueno Tofani; Lívia Vieira Depieri; Patrícia Mazureki Campos; Thalita Bachelli Riul; Kamilla Swiech Antonietto; Márcia Carvalho de Abreu Fantini; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

8.  Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity.

Authors:  Nitin K Swarnakar; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-11-12       Impact factor: 4.200

9.  Vertical Orientation of Liquid Crystal on Comb-Like 4-(trans-4-alkylcyclohexyl)phenoxymethyl-substituted Polystyrene Containing Liquid Crystal Precursor.

Authors:  Kyutae Seo; Hyo Kang
Journal:  Polymers (Basel)       Date:  2021-04-26       Impact factor: 4.329

10.  AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.

Authors:  Dorota K Flak; Vivian Adamski; Grzegorz Nowaczyk; Kosma Szutkowski; Michael Synowitz; Stefan Jurga; Janka Held-Feindt
Journal:  Int J Nanomedicine       Date:  2020-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.